×
S&P 500   4,158.24
DOW   33,212.96
QQQ   309.10
S&P 500   4,158.24
DOW   33,212.96
QQQ   309.10
S&P 500   4,158.24
DOW   33,212.96
QQQ   309.10
S&P 500   4,158.24
DOW   33,212.96
QQQ   309.10
LON:SPEC

Inspecs Group (SPEC) Share Forecast, Price & News

GBX 343
+2.00 (+0.59%)
(As of 05/27/2022 12:00 AM ET)
Add
Compare
Today's Range
336
348
50-Day Range
320
369.90
52-Week Range
305
420
Volume
36,192 shs
Average Volume
55,439 shs
Market Capitalization
£348.73 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A
30 days | 90 days | 365 days | Advanced Chart
Receive SPEC News and Ratings via Email

Sign-up to receive the latest news and ratings for Inspecs Group and its competitors with MarketBeat's FREE daily newsletter.

Inspecs Group logo

About Inspecs Group

Inspecs Group PLC designs, produces, sells, markets, and distributes fashion eyewear and original equipment manufacturer products worldwide. It provides a range of branded and private label optical and sunglasses frames. Inspecs Group PLC offers its products directly to retailers, distributors, and brand partners. The company also sells its products through a network of approximately 70,000 points of sale in 80 countries worldwide. Inspecs Group PLC was founded in 1988 and is headquartered in Bath, the United Kingdom.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Medical Instruments & Supplies
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
1,800
Year Founded
N/A

Sales & Book Value

Annual Sales
£156.43 million
Cash Flow
GBX 38.09 per share
Book Value
GBX 145.30 per share

Profitability

Pretax Margin
N/A

Debt

Price-To-Earnings

Miscellaneous

Free Float
N/A
Market Cap
£348.73 million
Optionable
Not Optionable

MarketRank

Overall MarketRank

1.50 out of 5 stars

Analyst Opinion: 2.5Community Rank: 5.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -













Inspecs Group (LON:SPEC) Frequently Asked Questions

Is Inspecs Group a buy right now?

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Inspecs Group in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Inspecs Group stock.
View analyst ratings for Inspecs Group
or view top-rated stocks.

What price target have analysts set for SPEC?

2 analysts have issued 12-month price targets for Inspecs Group's stock. Their forecasts range from GBX 425 to GBX 425. On average, they anticipate Inspecs Group's share price to reach GBX 425 in the next year. This suggests a possible upside of 23.9% from the stock's current price.
View analysts' price targets for Inspecs Group
or view top-rated stocks among Wall Street analysts.

Who are Inspecs Group's key executives?
Inspecs Group's management team includes the following people:
  • Mr. Robin B.C. Totterman, Founder, Group CEO & Director (Age 61, Pay $189.19k)
  • Mr. Christopher D. Kay, Group CFO & Director (Age 59, Pay $152.18k)
  • Martin Bates, Sales Director
  • Mr. Steve Tulba, Managing Director of Inspecs Division
  • Mr. Richard McGonigle, Company Sec.
What is Inspecs Group's stock symbol?

Inspecs Group trades on the London Stock Exchange (LON) under the ticker symbol "SPEC."

How do I buy shares of Inspecs Group?

Shares of SPEC and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Inspecs Group's stock price today?

One share of SPEC stock can currently be purchased for approximately GBX 343.

How much money does Inspecs Group make?

Inspecs Group has a market capitalization of £348.73 million and generates £156.43 million in revenue each year.

How many employees does Inspecs Group have?

Inspecs Group employs 1,800 workers across the globe.

What is Inspecs Group's official website?

The official website for Inspecs Group is inspecs.com.

How can I contact Inspecs Group?

The company can be reached via phone at 44 1125 717 000.

This page was last updated on 5/28/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.